Publications by authors named "Mark Huffmyer"

Claim this Profile
P
Perspectives on the clinical use of anti-amyloid therapy for the treatment of Alzheimer's disease: Insights from the fields of cancer, rheumatology, and neurology.
Gregory A Jicha, Erin L Abner, Elif P Coskun, Mark J Huffmyer, Thomas C Tucker

Alzheimers Dement (N Y)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rural disparities in emergency department utilization for migraine care.
Christian Rhudy, Aric Schadler, Mark Huffmyer, Lindsey Porter

Headache· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceptability of patient-centered, multi-disciplinary medication therapy management recommendations: results from the INCREASE randomized study.
Noah I Smith, Ashley I Martinez, Mark Huffmyer, Lynne Eckmann, Rosmy George

BMC Geriatr· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists.
Kaylee M Lukacena, James W Keck, Patricia R Freeman, Nancy Grant Harrington, Mark J Huffmyer

Ther Adv Drug Saf· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary care clinician and community pharmacist perceptions of deprescribing.
Mark J Huffmyer, James W Keck, Nancy Grant Harrington, Patricia R Freeman, Matthew Westling

J Am Geriatr Soc· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Year Evaluation of a Targeted Medication Therapy Management Intervention for Older Adults.
Ashley I Martinez, Erin L Abner, Gregory A Jicha, Dorinda N Rigsby, Lynne C Eckmann, Mark J Huffmyer

J Manag Care Spec Pharm· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer's Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol.
Daniela C Moga, Brooke F Beech, Erin L Abner, Frederick A Schmitt, Riham H El Khouli, Mark Huffmyer

Trials· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing medication appropriateness in older adults: a randomized clinical interventional trial to decrease anticholinergic burden.
Daniela C Moga, Erin L Abner, Dorinda N Rigsby, Lynne Eckmann, Mark Huffmyer

Alzheimers Res Ther· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis